Eucrisa – A New Cream For Eczema

By |2021-10-19T03:16:46-07:00April 19th, 2017|RSS|

A new topical medication, Eucrisa, for treating eczema has recently been approved by the FDA. With keen interest I read every word of the backup study and publication in the Journal of the American Academy of Dermatology concerning then named Opa-15406, a novel topical non-steroidal PDE4 inhibitor. The study included patients who had just recently [...]

Comments Off on Eucrisa – A New Cream For Eczema

Academy Of Dermatology Poster

By |2021-10-19T03:16:46-07:00April 17th, 2017|RSS Patients|

A physician, Tim Berger, presented a poster at the recent March, 2017, Academy of Dermatology meeting. In essence he implies that he discovered TSA, TSW and RSS with the caveat that these patients itch. It is evident that he never saw any of the patients, since this was only a survey from the internet. The [...]

Comments Off on Academy Of Dermatology Poster

Dupilumab Study – Subject Patient Comments

By |2019-12-12T18:13:55-08:00April 6th, 2017|Dupilumab|

The Dupilumab studies were 16 weeks long. This is a very short time to truly evaluate a drug in this very difficult and prolonged skin problem. In addition, there were no objective comments on rash, redness, skin oozing, edema and pain. There are no long term follow ups reported. But: Links to patient comments after [...]

Comments Off on Dupilumab Study – Subject Patient Comments

Dupilumab Study – Are Eczema Patients Being ‘duped’ Again?

By |2021-10-19T03:16:46-07:00April 4th, 2017|Dupilumab|

My most recent postings have dissected the protocol, the patients, the methods and the fine print of the Dupilumab studies reported in the medical literature. Severe failings are evident in all the above criteria. What, therefore can we expect from the results and conclusions? This assessment will group together all Dupilumab studies. My findings are: [...]

Comments Off on Dupilumab Study – Are Eczema Patients Being ‘duped’ Again?

Dupilumab – Does the Drug Work?

By |2021-10-19T03:16:46-07:00April 3rd, 2017|Dupilumab|

The Dupilumab studies as reported in the New England Journal of Medicine and the Journal of the American Academy of Dermatology and by me on discussed in my four prior posts exhibit multiple violations in the study of new drugs and scientific reporting. Inclusion of patients: from my experience with 4000 totally similar patients none [...]

Comments Off on Dupilumab – Does the Drug Work?

Dupilumab – Horror Movie

By |2019-12-12T18:13:56-08:00March 31st, 2017|Dupilumab|

In recounting the diagnosis, management and cure of 4000 corticosteroid addicted atopic dermatitis patients I feel like I am in a futuristic movie with a split screen simultaneously showing two similar populations. One population is now in the present consisting of suffering patients who go on to CURE – albeit through a prolonged period of [...]

Comments Off on Dupilumab – Horror Movie

Dupilumab Study – Journal Articles

By |2021-10-19T03:16:46-07:00March 30th, 2017|Dupilumab|

Dupilumab is now FDA approved as of March 28, 2017 and this event necessitates a further evaluation for the prospects of this drug helping eczema patients. Physicians and patients are being told the published results but they deserve an objective critique. There are multiple discrepancies and violations of true, honest research and in looking at [...]

Comments Off on Dupilumab Study – Journal Articles

Dupilumab: Further Comments

By |2021-10-19T03:16:46-07:00March 28th, 2017|Dupilumab|

After having cured 4000 plus patients with steroid addiction and Red Skin Syndrome, I feel duty bound to offer sound advice to those still mismanaged suffering patients still floundering in their care. In that regard I look at every new drug offering promise of improvement or cure to these patients. I dissect the quality of [...]

Comments Off on Dupilumab: Further Comments

Dupilumab Study

By |2021-10-19T03:16:46-07:00March 22nd, 2017|Dupilumab, RSS Patients|

The following are comments by Marvin Rapaport MD, owner of this website, Red Skin Syndrome, and edited and clearly written by an esteemed writer and journalist, Ruchy Reese, who writes for the monthly magazine, Wellspring.   I am writing in response to an article that appeared in the December 15, 2016 edition of the New [...]

Comments Off on Dupilumab Study

My Journey

By |2019-12-12T18:13:56-08:00March 14th, 2017|Information on Red Skin Syndrome, Topical Steroid Withdrawal|

Dr. Rapaport, I recently came across one of the pictures of my Topical Steroid Withdrawal/Red Skin Syndrome (TSW/RSS) journey. It was of my lips – swollen, red, burning, peeling, splitting. Some symptoms were apparent before stopping TS, yet several dermatologists continued to prescribe them, Protopic and Elidel. I also endured probably all of the other [...]

Comments Off on My Journey
Go to Top